Cited by 352Chemokine receptors and signalingAngiogenesis and VEGF in CancerImmune cells in cancer

The DOI matches its Crossref record; 164 of the 173 references it cites were found in a registry or an index.

Chemokines in cancer

Vicari, Alain P, Caux, Christophe·2002·Cytokine & Growth Factor Reviews

Open this paper in CoChat — free account

Abstract

Chemokines participate, by regulating cell trafficking and controlling angiogenesis, in the host response during infection and inflammation. Most of these mechanisms are also operating in cancer. The stimulation of angiogenesis and tumor growth--directly or indirectly through the recruitment of tumor-associated macrophages--are typical situations where chemokines promote tumor development. On the other hand, chemokines could be used to the benefit of cancer patients as they act in the recruitment of dendritic cells (DC) or/and effector cells or for their angiostatic properties. However, chemokine-mediated recruitment of immature DC within tumors, due to factors produced by the tumor milieu, could lead to the induction of immune tolerance and, therefore, novel strategies to eradicate tumors based on chemokines should attempt to avoid this risk.

Integrity signals

Registry

Crossref · 10.1016/s1359-6101(01)00033-8

Cites

164 of 164 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,496
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Chemokines
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O’Garra, A., Bigler, M., Rouleau, M., Antonenko, S. V., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
Albert, M. L., Sauter, B., & Bhardwaj, N. (1998) · Nature · doi:10.1038/32183 · Cited by 2,350
CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner‐Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,348

Show all 173 references

Research works printed but not linked: 1

Rollins, 1997, Chemokines. Blood, 90, 909, 10.1182/blood.V90.3.909 · DOI

Sorted by citations

Items 101–200 of 352

Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment
Lee, S. W. L., Seager, R. J., Litvak, F., Spill, F., Sieow, J. L., Leong, P. H., Kumar, D., Tan, A. S. M., Wong, S. C., Adriani, G., et al. (2020) · Integrative Biology · doi:10.1093/intbio/zyaa007 · Cited by 60
Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma: pattern of expression and correlation with clinical outcome
Wang, N., Wu, Q., Fang, Y., Mai, H., Zeng, M., Shen, G., Hou, J., & Zeng, Y. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-26 · Cited by 60
Nox1 Expression Determines Cellular Reactive Oxygen and Modulates c-fos-Induced Growth Factor, Interleukin-8, and Cav-1
Arnold, R. S., He, J., Remo, A., Ritsick, D. R., Yin-Goen, Q., Lambeth, J. D., Datta, M. W., Young, A. N., & Petros, J. A. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.061144 · Cited by 60
CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells
Lepsenyi, M., Algethami, N., Al-Haidari, A. A., Algaber, A. A., Syk, I., Rahman, M., & Thorlacius, H. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10103-0 · Cited by 59
Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer
Razmkhah, M., Doroudchi, M., Ghayumi, S. M. A., Erfani, N., & Ghaderi, A. A. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.04.014 · Cited by 59
Inhibition of stromal CXCR4 impairs development of lung metastases
D’Alterio, C., Barbieri, A., Portella, L., Palma, G., Polimeno, M., Riccio, A., Ieranò, C., Franco, R., Scognamiglio, G., Bryce, J., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1223-7 · Cited by 60
MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA
Al-Haidari, A. A., Syk, I., & Thorlacius, H. (2017) · Oncotarget · doi:10.18632/oncotarget.14841 · Cited by 59
Elevated serum RANTES levels in patients with ovarian cancer correlate with the extent of the disorder
Tsukishiro, S., Suzumori, N., Nishikawa, H., Arakawa, A., & Suzumori, K. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.01.029 · Cited by 58
Mycobacterium bovis bacillus Calmette–Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo
Luo, Y., Chen, X., & O’Donnell, M. A. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03288.x · Cited by 58
Pathophysiology of tumor neovascularization
Furuya, M., Nishiyama, M., Kasuya, Y., Kimura, S., & Ishikura, H. (2005) · Vascular Health and Risk Management · doi:10.2147/vhrm.2005.1.4.277 · Cited by 59
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy
Sapoznik, S., Ortenberg, R., Galore-Haskel, G., Kozlovski, S., Levy, D., Avivi, C., Barshack, I., Cohen, C. J., Besser, M. J., Schachter, J., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1245-1 · Cited by 56
Differential roles of PI3-Kinase, MAPKs and NF-κB on the manipulation of dendritic cell Th1/Th2 cytokine/chemokine polarizing profile
Neves, B. M., Cruz, M. T., Francisco, V., García‐Rodríguez, C., Silvestre, R., Cordeiro‐da‐Silva, A., Dinis, A. M., Batista, M. T., Duarte, C. B., & Lopes, M. C. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.021 · Cited by 57
CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cellsin vitro
Burgess, M. L., Cheung, C. W. Y., Chambers, L., Ravindranath, K. J., Minhas, G., Knop, L., Mollee, P. N., McMillan, N. A. J., & Gill, D. S. (2012) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2012.672735 · Cited by 55
Positron Emission Tomography Imaging of Tumors Expressing the Human Chemokine Receptor CXCR4 in Mice with the Use of 64Cu-AMD3100
Weiss, I. D., Jacobson, O., Kiesewetter, D. O., Jacobus, J. P., Szajek, L. P., Chen, X. S., & Farber, J. M. (2011) · Molecular Imaging and Biology · doi:10.1007/s11307-010-0466-y · Cited by 56
A systems biology approach reveals common metastatic pathways in osteosarcoma
Flores, R. J., Li, Y., Yu, A. K.-T., Shen, J. J., Rao, P. H., Lau, S. S., Vannucci, M., Lau, C. C., & Man, T. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-50 · Cited by 51
The chemokine CXCL9 expression is associated with better prognosis for colorectal carcinoma patients
Wu, Z., Huang, X., Han, X., Li, Z., Zhu, Q., Yan, J., Yu, S., Jin, Z., Wang, Z., Zheng, Q., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.021 · Cited by 53
Protective role of the polymorphism CCR2-64I in the progression from squamous intraepithelial lesions to invasive cervical carcinoma
Coelho, A., Matos, A., Catarino, R., Pinto, D., Pereira, D., Lopes, C., & Medeiros, R. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.11.028 · Cited by 53
Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma
Chang, K., Wu, C., Fang, K., Tsai, C., Chang, Y., Liu, S.-C., & Kao, H. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2013.05.006 · Cited by 52
The Multifaceted Roles of CXCL9 Within the Tumor Microenvironment
Neo, S., & Lundqvist, A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-36667-4_5 · Cited by 52
Enhanced Expression and Clinical Significance of Chemokine Receptor CXCR2 in Hepatocellular Carcinoma
Liu, Z., Yang, L., Xu, J., Zhang, X., & Wang, B. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.07.014 · Cited by 51
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis
Hu, Z., Brooks, S. A., Dormoy, V., Hsu, C.-W., Hsu, H.-Y., Lin, L., Massfelder, T., Rathmell, W. K., Xia, M., Al‐Mulla, F., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv036 · Cited by 51
Expression Analysis and Potential Functional Role of the CXCR4 Chemokine Receptor in Bladder Cancer
Eisenhardt, A., Frey, U. H., TACK, M., Rosskopf, D., Lümmen, G., Rubben, H., & Siffert, W. (2004) · European Urology · doi:10.1016/j.eururo.2004.10.001 · Cited by 49
Location, movement and survival: the role of chemokines in haematopoiesis and malignancy
Laurence, A. D. J. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05841.x · Cited by 50
Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins
Nasser, M. W., Elbaz, M., Ahirwar, D. K., & Ganju, R. K. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.05.002 · Cited by 48
Involvement of the nuclear factor-κB signaling pathway in the regulation of CXC chemokine receptor-4 expression in neuroblastoma cells induced by tumor necrosis factor-α
Zhi, Y., Lu, H., Duan, Y., Sun, W.-S. W., Guan, G., Dong, Q., & Yang, C.-M. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.2032 · Cited by 47
The Cytokine Gene CXCL14 Restricts Human Trophoblast Cell Invasion by Suppressing Gelatinase Activity
Kuang, H., Chen, Q., Zhang, Y., Zhang, L., Peng, H., Ning, L., Cao, Y., & Duan, E. (2009) · Endocrinology · doi:10.1210/en.2009-0570 · Cited by 47
High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma
Han, L., Jiang, B., Wu, H., Wang, X., Tang, X., Huang, J., & Zhu, J. (2012) · Medical Oncology · doi:10.1007/s12032-011-0152-1 · Cited by 45
Role of chemokines and chemokine receptors in prostate cancer development and progression.
Singh, R. K., Sudhakar, A., & Lokeshwar, B. L. (2010) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000030 · Cited by 45
Ovarian Cancer Stroma: Pathophysiology and the Roles in Cancer Development
Furuya, M. (2012) · Cancers · doi:10.3390/cancers4030701 · Cited by 44
Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets
Schmid‐Alliana, A., Schmid‐Antomarchi, H., Al-Sahlanee, R., Lagadec, P., Scimeca, J., & Verron, É. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010148 · Cited by 45
MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2
Duan, S., Dong, X., Hai, J., Jiang, J., Wang, W., Yang, J., Zhang, W., & Chen, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.044 · Cited by 45
Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response
Neves, S., Faneca, H., Bertin, S., Konopka, K., Düzgüneş, N., Pierrefite‐Carle, V., Simões, S., & de Lima, M. C. P. (2008) · Cancer Gene Therapy · doi:10.1038/cgt.2008.60 · Cited by 44
Linking Inflammation Reactions to Cancer: Novel Targets for Therapeutic Strategies
Mantovani, A., Marchesi, F., Porta, C., Allavena, P., & Sica, A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73898-7_9 · Cited by 43
Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma
Zhang, X., Hu, Z., Meng, A., Duan, G., Zhao, Q., & Yang, J. H. (2017) · Oncology Letters · doi:10.3892/ol.2017.7253 · Cited by 43
Pretreatment Interleukin‐6 Serum Levels Are Associated with Patient Survival for Oral Cavity Squamous Cell Carcinoma
Chang, K., Kao, H., Wu, C., Fang, K., Chang, Y., Huang, Y., Liu, S.-C., & Cheng, M. (2013) · Otolaryngology · doi:10.1177/0194599813478573 · Cited by 43
RETRACTED ARTICLE: CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling
Al-Haidari, A. A., Syk, I., Jirström, K., & Thorlacius, H. (2013) · International Journal of Colorectal Disease · doi:10.1007/s00384-013-1712-y · Cited by 43
Retracted
Improvement of CXCR4 tracer specificity for PET imaging
Jacobson, O., Weiss, I. D., Szajek, L. P., Niu, G., Ma, Y., Kiesewetter, D. O., Peled, A., Eden, H. S., Farber, J. M., & Chen, X. S. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.076 · Cited by 42
Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis
Furuya, M., Yoneyama, T., Miyagi, E., Tanaka, R. J., Nagahama, K., Miyagi, Y., Nagashima, Y., Hirahara, F., Inayama, Y., & Aoki, I. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.05.034 · Cited by 43
Tumour-immune cell interactions modulated by chemokines
Jöhrer, K., Pleyer, L., Olivier, A., Maizner, E., Zelle‐Rieser, C., & Greil, R. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.3.269 · Cited by 41
Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis
Nahon, P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.713 · Cited by 41
Prognostic Significance of CD4+ and CD8+ T Cell Infiltration Within Cancer Cell Nests in Vulvar Squamous Cell Carcinoma
Sznurkowski, J. J., Żawrocki, A., Emerich, J., & Biernat, W. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182131f36 · Cited by 41
Androgen receptor (AR) signaling promotes RCC progression via increased endothelial cell proliferation and recruitment by modulating AKT → NF-κB → CXCL5 signaling
Guan, Z., Li, C., Fan, J., He, D., & Li, L. (2016) · Scientific Reports · doi:10.1038/srep37085 · Cited by 40
Toll‐like receptor 3 signal augments radiation‐induced tumor growth retardation in a murine model
Yoshida, S., Shime, H., Takeda, Y., Nam, J., Takashima, K., Matsumoto, M., Shirato, H., Kasahara, M., & Seya, T. (2018) · Cancer Science · doi:10.1111/cas.13543 · Cited by 40
Study on CXCR4/SDF-1a axis in lymph node metastasis of cervical squamous cell carcinoma
Zhang, J.-P., Lu, W.-G., Ye, F., CHEN, H.-Z., Zhou, C.-Y., & Xie, X. (2007) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2007.00786.x · Cited by 40
CXC Chemokine Ligand 12 (Stromal Cell-Derived Factor 1α) and CXCR4-Dependent Migration of CTLs toward Melanoma Cells in Organotypic Culture
Zhang, T., Somasundaram, R., Berencsi, K., Caputo, L., Rani, P., Guerry, D., Furth, E. E., Rollins, B. J., Putt, M. E., Gimotty, P. A., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5856 · Cited by 40
Clinical application and prospect of immune checkpoint inhibitors for CAR-NK cell in tumor immunotherapy
Yang, K., Zhao, Y., Sun, G., Zhang, X., Cao, J., Shao, M.-C., Liang, X., & Wang, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1081546 · Cited by 42
Dedicator of Cytokinesis 2 in Cell Signaling Regulation and Disease Development
Guo, X., & Chen, S. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25512 · Cited by 40
Tumor immune escape mechanisms: impact of the neuroendocrine system
Lang, K., Entschladen, F., Weidt, C., & Zaenker, K. S. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0126-x · Cited by 39
Association of CCL2 with Lymph Node Metastasis and Macrophage Infiltration in Oral Cavity and Lip Squamous Cell Carcinoma
Ferreira, F. D. O., Ribeiro, F. L. L., Batista, A. C., Leles, C. R., Alencar, R. D. C. G., & Silva, T. A. (2008) · Tumor Biology · doi:10.1159/000137669 · Cited by 39
The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer
Küçükgergin, C., İşman, F. K., Daşdemir, S., Çakmakoğlu, B., Şanlı, Ö., Gökkuşu, C., & Seçkin, Ş. (2012) · Gene · doi:10.1016/j.gene.2012.09.011 · Cited by 38
Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women.
Attar, R., Ağaçhan, B., Kuran, S. B., Cacına, C., Sozen, S., Yurdum, L. M., Attar, E., & İşbir, T. (2010) · PubMed · Cited by 38
Breast Cancer and HIV in Sub-Saharan Africa: A Complex Relationship
Grover, S., Martei, Y. M., Puri, P. M., Prabhakar, P., Mutebi, M. C., Balogun, O., Price, A. J., Freeman, A. H., Narasimhamurthy, M., Rodin, D. L., et al. (2017) · Journal of Global Oncology · doi:10.1200/jgo.2016.006585 · Cited by 38
CCR2-64I is a risk factor for development of bladder cancer
Narter, F., Ağaçhan, B., Sozen, S., Çinçin, Z. B., & İşbir, T. (2010) · Genetics and Molecular Research · doi:10.4238/vol9-2gmr829 · Cited by 37
New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities
Poty, S., Désogère, P. A., Goze, C., Boschetti, F., D’huys, T., Schols, D., Cawthorne, C., Archibald, S. J., Maëcke, H. R., & Denat, F. (2015) · Dalton Transactions · doi:10.1039/c4dt02972k · Cited by 37
The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers
Midavaine, É., Côté, J., & Sarret, P. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09974-2 · Cited by 39
Prognostic cytokine markers in peripheral blood for oral cavity squamous cell carcinoma identified by multiplexed immunobead-based profiling
Chang, K., Chang, Y., Liao, C., Yen, T., Chen, I., Chang, Y., Liu, Y., Chang, Y., Yu, J., & Wu, C. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.02.002 · Cited by 37
Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in mice
Belo, A. V., Barcelos, L. S., Ferreira, M. A. N. D., Teixeira, M. M., & Andrade, S. P. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.072 · Cited by 37
Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma
Romero, J. M., Aptsiauri, N., Vazquez, F., Cozar, J. M., Cantón, J., Cabrera, T., Tallada, M., Garrido, F., & Ruiz‐Cabello, F. (2006) · Tissue Antigens · doi:10.1111/j.1399-0039.2006.00673.x · Cited by 37
In vitro migration of cytotoxic T lymphocyte derived from a colon carcinoma patient is dependent on CCL2 and CCR2
Berencsi, K., Rani, P., Zhang, T., Gross, L. A., Mastrangelo, M. J., Meropol, N. J., Herlyn, D., & Somasundaram, R. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-33 · Cited by 37
CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women
Chatterjee, K., Dandara, C., Hoffman, M. N., & Williamson, A. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-278 · Cited by 36
The role of cytokines in head and neck squamous cell carcinoma: A review.
Ralli, M., Grasso, M., Gilardi, A., Ceccanti, M., Messina, M. P., Tirassa, P., Fiore, M., ALTISSIMI, G., Salzano, F. A., VINCENTIIS, M. D., et al. (2020) · PubMed · doi:10.7417/ct.2020.2225 · Cited by 36
The Significance of CXCL1 and CXCL8 as Well as Their Specific Receptors in Colorectal Cancer
Łukaszewicz‐Zając, M., Pączek, S., Mroczko, P., & Kulczyńska‐Przybik, A. (2020) · Cancer Management and Research · doi:10.2147/cmar.s267176 · Cited by 36
Overexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasis
Chang, K., Kao, H., Yen, T., Chang, Y., Liang, Y. J., Liu, S.-C., Lee, L., Chang, Y., Kang, C., Chen, I., et al. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.11.012 · Cited by 36
HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation
Al-Haidari, A. A., Syk, I., & Thorlacius, H. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.078 · Cited by 36
Chemokine gene modification of human dendritic cell-based tumor vaccines using a recombinant adenoviral vector
Terando, A. M., Roessler, B. J., & Mulé, J. J. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700671 · Cited by 35
Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis
Cambien, B., Rezzonico, R., Vitale, S., Rouzaire-Dubois, B., Dubois, J., Barthel, R., Karimdjee-Soilihi, B., Mograbi, B., Schmid‐Alliana, A., & Schmid‐Antomarchi, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23511 · Cited by 35
Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators
Nagarajan, P., Chin, S. S., Wang, D., Liu, S., Sinha, S., & Garrett‐Sinha, L. A. (2010) · Journal of Cell Science · doi:10.1242/jcs.062240 · Cited by 38
Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors
Shim, H., Oishi, S., & Fujii, N. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.11.004 · Cited by 35
Zonula occludens‐1/NF‐κB/CXCL8: a new regulatory axis for tumor angiogenesis
Lesage, J., Suarez‐Carmona, M., Neyrinck-Leglantier, D., Grelet, S., Blacher, S., Hunziker, W., Birembaut, P. L., Noël, A., Nawrocki‐Raby, B., Gilles, C., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600890r · Cited by 37
Chemokines bind to sulfatides as revealed by surface plasmon resonance
Sandhoff, R., Grieshaber, H., Djafarzadeh, R., Sijmonsma, T., Proudfoot, A. E. I., Handel, T. M., Wiegandt, H., Nelson, P. J., & Gröne, H. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.11.011 · Cited by 35
Infection and cancer: the common vein
Thomas‐Tikhonenko, A., & Hunter, C. A. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00071-0 · Cited by 34
Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis
Furuya, M., Tanaka, R. J., Miyagi, E., Kami, D., Nagahama, K., Miyagi, Y., Nagashima, Y., Hirahara, F., Inayama, Y., & Aoki, I. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.20084 · Cited by 35
Expression of Stromal Cell-Derived Factor 1 and CXCR7 in Papillary Thyroid Carcinoma
Liu, Z., Sun, D.-X., Teng, X., Xu, W.-X., Meng, X., & Wang, B. (2012) · Endocrine Pathology · doi:10.1007/s12022-012-9223-x · Cited by 33
C‐C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment
Urata, S., Izumi, K., Hiratsuka, K., Maolake, A., Natsagdorj, A., Shigehara, K., Iwamoto, H., Kadomoto, S., Makino, T., Naito, R., et al. (2017) · Cancer Science · doi:10.1111/cas.13494 · Cited by 33
The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing
Mühlethaler‐Mottet, A., Liberman, J., Ascenção, K., Flahaut, M., Bourloud, K. B., Yan, P., Jauquier, N., Groß, N., & Joseph, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125616 · Cited by 33
Establishment of a heterotypic 3D culture system to evaluate the interaction of TREG lymphocytes and NK cells with breast cancer
Augustine, T. N., Dix‐Peek, T., Duarte, R. A. B., & Candy, G. P. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.07.003 · Cited by 32
The Δ32 allele distribution of the CCR5 gene and its relationship with certain cancers in a Turkish population
Değerli, N., Yılmaz, E., & Bardakçi, F. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.11.001 · Cited by 32
CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion
Fan, L., Zhu, Q., Liu, L., Zhu, C., Huang, H., Lu, S., & Liu, P. (2017) · Oncotarget · doi:10.18632/oncotarget.18387 · Cited by 31
Mechanical Stimulation after Centrifuge‐Free Nano‐Electroporative Transfection Is Efficient and Maintains Long‐Term T Cell Functionalities
Tay, A. K. P., & Melosh, N. A. (2021) · Small · doi:10.1002/smll.202103198 · Cited by 31
Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells
Wang, L., Huang, T., Chen, W., Gao, X., Zhou, T. T., Wu, Z., & Sun, Y. (2012) · Oncology Reports · doi:10.3892/or.2012.2028 · Cited by 31
Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer
Wertel, I., Polak, G., Bednarek, W., Barczyński, B., Roliński, J., & Kotarski, J. (2008) · Cytometry Part B Clinical Cytometry · doi:10.1002/cyto.b.20410 · Cited by 33
Cytokine-like 1 is involved in the growth and metastasis of neuroblastoma cells
Wen, M., Wang, H., Zhang, X., LONG, J., Lv, Z., Kong, Q., & An, Y. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1552 · Cited by 30
AMD3100: A Versatile Platform for CXCR4 Targeting 68Ga-Based Radiopharmaceuticals
Poty, S., Gourni, E., Désogère, P. A., Boschetti, F., Goze, C., Maëcke, H. R., & Denat, F. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00689 · Cited by 30
Genetic Susceptibility for Cervical Cancer in African Populations: What Are the Host Genetic Drivers?
Kuguyo, O., Tsikai, N., Thomford, N. E., Magwali, T. L., Madziyire, M. G., Nhachi, C. F. B., Matimba, A., & Dandara, C. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0075 · Cited by 32
Recent progress in the design of DNA vaccines against tuberculosis
Sefidi-Heris, Y., Jahangiri, A., Mokhtarzadeh, A., Shahbazi, M., Khalili, S., Baradaran, B., Mosafer, J., Baghbanzadeh, A., Hejazi, M., Hashemzaei, M., et al. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.005 · Cited by 30
Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response
Flanagan, K., Glover, R. T., Hörig, H., Yang, W., & Kaufman, H. L. (2004) · Vaccine · doi:10.1016/j.vaccine.2003.12.021 · Cited by 30
CX3CL1: a potential chemokine widely involved in the process spinal metastases
Liu, W., Bian, C., Liang, Y., Jiang, L., Qian, C., & Dong, J. (2017) · Oncotarget · doi:10.18632/oncotarget.14773 · Cited by 31
Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell.
Liu, L., Xie, F., Chang, K., Shang, W.-Q., Meng, Y., Yu, J., Li, H., Sun, Q., Yuan, M., Jin, L., et al. (2015) · Europe PMC (PubMed Central) · Cited by 29
CCL27–CCR10 and CXCL12–CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma
Monteagudo, C. C., Ramos, D., Pellín-Carcelén, A., Gil, R., Callaghan, R. C., Martín, J. M., Alonso, V., Murgui, A., Navarro, L., Fariñas, S. C., et al. (2012) · Clinical & Experimental Metastasis · doi:10.1007/s10585-012-9476-2 · Cited by 29
Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil
Cavassin, G. G. D. O., Lucca, F. L. D., André, N. D., Covas, D. T., Fungaro, M. H. P., Voltarelli, J. C., & Watanabe, M. A. E. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2004.04.008 · Cited by 29
Role of mesenchymal cells in the natural history of ovarian cancer: a review
Touboul, C., Vidal, F., Pasquier, J., Lis, R., & Rafii, A. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0271-5 · Cited by 29
Antitumor immune activity by chemokine CX3CL1 in an orthotopic implantation of lung cancer model in vivo
Kee, J., Arita, Y., Shinohara, K., Ohashi, Y., Sakurai, H., Saiki, I., & Koizumi, K. (2012) · Molecular and Clinical Oncology · doi:10.3892/mco.2012.30 · Cited by 28
The Glycerophosphoinositols: From Lipid Metabolites to Modulators of T-Cell Signaling
Patrussi, L., Mariggiò, S., Corda, D., & Baldari, C. T. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00213 · Cited by 28
The saponin DT-13 inhibits gastric cancer cell migration through down-regulation of CCR5-CCL5 axis
Lin, S., Fan, W. Q., Sun, L., Li, F., Zhao, R., Zhang, L., Yu, B., & Yuan, S. (2014) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(14)60125-4 · Cited by 28
Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod
Torres, A., Storey, L., Anders, M., Miller, R. L., Bulbulian, B. J., Jin, J., Raghavan, S., Lee, J., Slade, H. B., & Birmachu, W. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08218.x · Cited by 28
A complex pattern of chemokine receptor expression is seen in osteosarcoma
von Luettichau, I., Segerer, S., Wechselberger, A., Notohamiprodjo, M., Nathrath, M., Kremer, M., Henger, A., Djafarzadeh, R., Burdach, S. E. G., Huss, R., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-23 · Cited by 28
Midkine, a heparin-binding growth factor, produced by the host enhances metastasis of Lewis lung carcinoma cells
Salama, R. H. M., Muramatsu, H., Zou, P., Okayama, M., & Muramatsu, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.02.047 · Cited by 27
IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy
Zheng, J., Wang, X., Yu, J., Zhan, Z., & Guo, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.997665 · Cited by 26
Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma
Hsin, L., Kao, H., Chen, I., Tsang, N., Hsu, C., Liu, S.-C., Chang, Y., & Chang, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080052 · Cited by 26
Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study
Nahon, P., Sutton, A., Rufat, P., Faisant, C., Simon, C., Barget, N., Trinchet, J., Beaugrand, M., Gattegno, L., & Charnaux, N. (2007) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3280120e2b · Cited by 26

Authors: Vicari, A. P., & Caux, C.
Corresponding author: Vicari, Alain P
ORCID: Caux, Christophe
Venue: Cytokine & Growth Factor Reviews
Publisher: Elsevier BV
Published: 2002-04
Volume: 13
Issue: 2
Pages: 143-154
ISSN: 1359-6101 (ISSN-L)
DOI: 10.1016/s1359-6101(01)00033-8
OpenAlex: W2092021793
Cited by: 351
References: 173
Citations by year: 2025: 2 · 2024: 4 · 2023: 3 · 2022: 4 · 2021: 9 · 2020: 14 · 2019: 11 · 2018: 9 · 2017: 13 · 2016: 12 · 2015: 16 · 2014: 20 · 2013: 18 · 2012: 21
FWCI: 2.30
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Cytokine & Growth Factor Reviews (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords: chemokines, cancer, angiogenesis, tumor growth, tumor-associated macrophages, dendritic cell recruitment, immune tolerance, tumor microenvironment, cell trafficking
MeSH terms: Animals, Dendritic Cells, Humans, Killer Cells, Natural, Leukocytes, Models, Biological, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, T-Lymphocytes, Chemokines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Chemokines in cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks